- Report
- September 2025
- 182 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- July 2025
- 350 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- July 2025
- 140 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 189 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
- Report
- September 2025
- 383 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- January 2025
- 129 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- December 2024
- 88 Pages
Asia Pacific
From €3013EUR$3,450USD£2,617GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3379EUR$3,869USD£2,935GBP
- Report
- February 2024
- 202 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- October 2022
- 194 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- November 2023
- 124 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- January 2023
- 124 Pages
Global
From €1965EUR$2,250USD£1,707GBP
- Report
- January 2024
- 213 Pages
Global
From €4061EUR$4,650USD£3,528GBP

The Hepatitis B Vaccine market is a subset of the larger Infectious Disease Testing market. It is focused on the prevention of Hepatitis B, a viral infection that can cause serious liver damage. The vaccine is typically administered to infants and young children, as well as adults at risk of infection. The vaccine is also recommended for healthcare workers and those with multiple sexual partners. The market is driven by the need to protect vulnerable populations from the virus, as well as the increasing prevalence of the disease in certain regions.
Companies in the Hepatitis B Vaccine market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, and Pfizer. Show Less Read more